Have any questions? Feel free to contact us:
ypkpln@pln.co.id

Profile Kami

Pendirian

YPK PLN didirikan oleh PT PLN (Persero)
tahun 1993 berdasarkan Akte notaris  Ny. SP Henny Shidky SH No. 26 tanggal
22 Sep. 1993, bergerak di bidang  Pendidikan dan Sosial.

Status

Status YPK PLN adalah mandiri, tidak dibiayai/ menjadi beban PLN, dan tidak terkonsolidasi dengan Laporan Keuangan PLN.

Amanah

Sesuai dengan amanah pendiriannya, YPK PLN menyelenggarakan kegiatan pendidikan dan pemberian bantuan sosial.

Sumber Pendanaan

  • Dividen Unit Usaha Yayasan.
  • Bagi-hasil dari Unit Usaha Yayasan.
  • Penyewaan aset Yayasan.
  • Bunga Deposito
  • Hibah

Unit Usaha dan Investasi

Guna memastikan keberlangsungan sumber pendanaan kegiatan, maka YPK PLN memiliki  Unit-unit Usaha (Perusahaan) dan Investasi pada beberapa Perusahaan

Pendidikan

Saat ini YPK PLN memiliki dan menyelenggarakan 1 institusi Perguruan Tinggi Institut Teknologi PLN dan 2 sekolah PAUD

Bahan_Kampus4
YPK-PLN

Our consultants have similar professional and educational backgrounds to those at generalist strategy consulting firms but with a significant advantage: 100% of Putnam’s work is dedicated to maximizing the value of the pharmaceutical, biotechnology, diagnostic and device products.

Integrity
OPERATIONAL EXCELLENCE
INNOVATION
CONTINUOUS IMPROVEMENT

Bringing quality and safety to life.

Watch our presentation video
Just send us your questions and we will give you the help you need.
placeholder

Our focus enables us to provide customized, actionable recommendations that draw.

Our focus enables us to provide customized, actionable recommendations that draw on robust problem framing, cutting-edge methodologies, deep therapeutic area knowledge, extensive global networks of health care stakeholders, and expert synthesis across scientific, clinical, and business disciplines.

Putnam’s work is dedicated to maximizing the value of the pharmaceutical, biotechnology, diagnostic and device products. We serve clients who market many of the world’s best-known biopharmaceuticals, and who are leveraging the genomics and “big data” revolutions month by month with new breakthrough therapies and higher quality patient care.

Bernie Clinton

FOUNDER

placeholder